Log in

Solarvest Bioenergy Stock Price, Forecast & Analysis (CVE:SVS)

+0.02 (+12.50 %)
(As of 11/19/2019 08:53 AM ET)
Today's Range
Now: C$0.14
50-Day Range
MA: C$0.15
52-Week Range
Now: C$0.14
Volume6,000 shs
Average Volume24,508 shs
Market CapitalizationC$4.63 million
P/E RatioN/A
Dividend YieldN/A
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. Its algal-based production systems are used to produce nutritional nutraceuticals, pharmaceutical oils, and biologic active ingredients/therapies. The company is developing algae strains for the food enhancement and nutraceutical markets; and producing proteins as a therapeutic. It has a collaborative research and development agreement with FSD Pharma Inc. to develop algae-based pharma-grade cannabinoids. Solarvest BioEnergy Inc. was incorporated in 2005 and is based in Vancouver, Canada.

Industry, Sector and Symbol

Industry Conglomerates



Sales & Book Value

Annual SalesN/A
Cash FlowC$0.01 per share
Book ValueC($0.07) per share



Market CapC$4.63 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SVS News and Ratings via Email

Sign-up to receive the latest news and ratings for SVS and its competitors with MarketBeat's FREE daily newsletter.

Solarvest Bioenergy (CVE:SVS) Frequently Asked Questions

What is Solarvest Bioenergy's stock symbol?

Solarvest Bioenergy trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVS."

Has Solarvest Bioenergy been receiving favorable news coverage?

Press coverage about SVS stock has trended very negative this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Solarvest Bioenergy earned a coverage optimism score of -3.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Solarvest Bioenergy.

Who are some of Solarvest Bioenergy's key competitors?

Who are Solarvest Bioenergy's key executives?

Solarvest Bioenergy's management team includes the folowing people:
  • Mr. Kenneth Anthony Cawkell B.A., LL.B., Chairman & Corp. Sec. (Age 68)
  • Mr. Gerri J. Greenham, Pres, CEO & Director (Age 68)
  • Mr. Ching-Hiang Heng, Chief Financial Officer (Age 73)
  • Mr. Garth Greenham, Chief Operating Officer

How do I buy shares of Solarvest Bioenergy?

Shares of SVS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Solarvest Bioenergy's stock price today?

One share of SVS stock can currently be purchased for approximately C$0.14.

How big of a company is Solarvest Bioenergy?

Solarvest Bioenergy has a market capitalization of C$4.63 million. View Additional Information About Solarvest Bioenergy.

What is Solarvest Bioenergy's official website?

The official website for Solarvest Bioenergy is http://www.solarvest.ca/.

How can I contact Solarvest Bioenergy?

Solarvest Bioenergy's mailing address is 439 Helmcken St, VANCOUVER, BC V6B 2E6, Canada. The company can be reached via phone at +1-604-6843323.

MarketBeat Community Rating for Solarvest Bioenergy (CVE SVS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  82
MarketBeat's community ratings are surveys of what our community members think about Solarvest Bioenergy and other stocks. Vote "Outperform" if you believe SVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel